Innovating Works

AOU MEYER IRCCS

Desconocido
ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE AZIENDA OSPEDALIERA UNIVERSITARIA MEYER IRCCS participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado
PALLIAKID: COMPREHENSIVE PAEDIATRIC PALLIATIVE CARE APPROACH AZIENDA OSPEDALIERA UNIVERSITARIA MEYER IRCCS participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 PALLIAKID is an interdisciplinary project aiming to evaluate the feasibility, effectiveness, and cost-effectiveness of novel interventions f...
2023-12-11 - 2028-05-31 | Financiado
PHEMS: Pediatric Hospitals as European drivers for multi-party computation and synthetic data generation ca... AZIENDA OSPEDALIERA UNIVERSITARIA MEYER IRCCS participó en un HORIZON EUROPE: HORIZON-HLTH-2022-IND-13 Cross-border collaboration can tackle the challenges in accessing relevant health data essential for international collaboration between sci...
2023-10-09 - 2026-09-30 | Financiado
3TR: Identification of the Molecular Mechanisms of non response to Treatments Relapses and Remission in... AZIENDA OSPEDALIERA UNIVERSITARIA MEYER IRCCS participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage 3TR is a transdisciplinary consortium made of experts in all areas of medicine, basic sciences and bioinformatics from academic institutions...
2019-08-22 - 2026-08-31 | Financiado
c4c: conect4children COllaborative Network for European Clinical Trials For Children AZIENDA OSPEDALIERA UNIVERSITARIA MEYER IRCCS participó en un H2020: H2020-JTI-IMI2-2016-10-two-stage Paediatric medicines development is embedded in the European policy, legislation and in the work of the pharmaceutical industry but currentl...
2018-06-22 - 2025-04-30 | Financiado
IC-Health: Improving digital health literacy in Europe AZIENDA OSPEDALIERA UNIVERSITARIA MEYER IRCCS participó en un H2020: H2020-SC1-2016-2017 Citizens' digital health literacy is an essential element for successful eHealth deployment. However, citizens often do not have the necessa...
2016-10-07 - 2018-10-31 | Financiado
CUREHLH: European initiative to improve knowledge treatment and survival of haemophagocytic syndromes in chi... AZIENDA OSPEDALIERA UNIVERSITARIA MEYER IRCCS participó en un FP7: Haemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening inherited immune disorder of early childhood characterised by an un...
Financiado
REBORNE: Regenerating Bone defects using New biomedical Engineering approaches AZIENDA OSPEDALIERA UNIVERSITARIA MEYER IRCCS participó en un FP7: Bone is among the most frequently transplanted tissue with about 1 million procedures annually in Europe. The worldwide market of bone repla...
Financiado
FIGHT-HLH: First Targeted Therapy to FIGHT Hemophagocytic Lymphohistiocytosis HLH A novel approach to HLH AZIENDA OSPEDALIERA UNIVERSITARIA MEYER IRCCS participó en un FP7: Hemophagocytic lymphohistiocytosis (HLH) is a rare, devastating disease characterized by uncontrolled immune response that primarily affects...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.